The Consumer Financial Protection Bureau (CFPB) has experienced noteworthy leadership and operational changes, potentially impacting the financial services sector under its regulation. This resource page serves as a comprehensive platform to stay informed about the latest, timely updates and developments from the CFPB.

Holland & Knight is proud to share its 2024 Private Equity Year in Review, highlighting the firm's continued leadership and strategic growth in the market, offering valuable perspectives on market trends and showcasing the firm's and our clients' achievements in 2024.

The Corporate Transparency Act (CTA) entered into force on Jan. 1, 2024. This federal legislation has introduced significant, new compliance burdens on Reporting Companies. Attorneys on Holland & Knight's Corporate Transparency Team can help you navigate this new law by advising on a Reporting Company's compliance obligations.

State and federal scrutiny of healthcare transactions is heating up, particularly where private equity sponsors are involved. Holland & Knight’s Healthcare Team has launched HK Navigator, an interactive map summarizing the scope and applicability of state laws requiring pre-closing notice and/or approval of certain healthcare transactions involving Management Services Organizations (MSOs) and Dental Support Organizations (DSOs).

Holland & Knight's Public Policy & Regulation Group is actively monitoring and reviewing President Trump's executive orders and other actions. Bookmark this page to follow along with key updates and analysis from our team.